In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014

被引:12
|
作者
Paczkowski, Magdalena [1 ]
Mwandama, Dyson [2 ]
Marthey, Daniel [3 ]
Luka, Madalitso [2 ]
Makuta, Georgina [2 ]
Sande, John
Ali, Doreen [4 ]
Troell, Peter [5 ]
Mathanga, Don P. [2 ]
Gutman, Julie [1 ]
机构
[1] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, 1600 Clifton Rd NE,Mailstop A06, Atlanta, GA 30329 USA
[2] Univ Malawi, Malaria Alert Ctr, Coll Med, Blantyre, Malawi
[3] US Peace Corps, Washington, DC USA
[4] Minist Hlth, Natl Malaria Control Programme, Lilongwe, Malawi
[5] US Ctr Dis Control & Prevent, US Presidents Malaria Initiat, Malaria Branch, Div Parasit Dis & Malaria, Lilongwe, Malawi
关键词
Plasmodium falciparum; Malawi; Artemether-lumefantrine; Artesunate-amodiaquine; ARTEMISININ-BASED COMBINATIONS; THERAPEUTIC-EFFICACY; CHILDREN; SAFETY; ARTEMETHER/LUMEFANTRINE;
D O I
10.1186/s12936-016-1281-y
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Malaria causes significant morbidity in Malawi, with an estimated 5 million cases in 2014. Artemether-lumefantrine (AL) and artesunate-amodiaquine (ASAQ) are the first-and second-line treatments for uncomplicated malaria, respectively, but emerging resistance threatens their efficacy. In order to understand whether AL and ASAQ remain efficacious for the treatment of uncomplicated Plasmodium falciparum malaria in Malawi, a therapeutic efficacy trial was conducted. Methods: During March-July 2014, febrile children aged 6-59 months with microscopy-confirmed uncomplicated P. falciparum malaria (1000-200,000 parasites/mu L) were enrolled in a 28-day randomized in vivo efficacy trial at three sites: one each in northern (Karonga), central (Nkhotakota) and southern (Machinga) Malawi. The study was powered to estimate site-specific efficacy for AL and overall efficacy for ASAQ, with 3:1 randomization to AL or ASAQ. Blood was collected for malaria microscopy and molecular testing on days 0-3, 7, 14, 21, and 28. Recrudescence and reinfection were differentiated using polymerase chain reaction (PCR) genotyping of merozoite surface protein. The primary outcome was the PCR-corrected day 28 Kaplan-Meier cumulative success rate. Results: A total of 452 children were enrolled; 303/338 (89 %) and 98/114 (86 %) reached a study endpoint in AL and ASAQ arms, respectively. All treatment failures occurred after day 3. The day 28 uncorrected cumulative success rate was 97.1 % (95 % confidence interval [CI]: 93.9-100 %) for ASAQ and 76.8 % (95 % CI 72.1-81.5 %) for AL, with 82.5 % (95 % CI 75.4-89.7 %), 69 % (95 % CI 59.9-78.1 %), and 78.2 % (95 % CI 70.2-86.3 %) success in the northern, central, and southern regions, respectively. The day 28 PCR-corrected cumulative success rate was 99 % (95 % CI 97.2-100 %) in the ASAQ arm and 99.3 % (95 % CI 98.3-100 %) in the AL arm, with 98-100 % efficacy in each site. Conclusions: As evidenced by the day 28 PCR-corrected cumulative success rates, both AL and ASAQ remain efficacious treatments for uncomplicated malaria in Malawi. The lower uncorrected efficacy in the AL arm compared to ASAQ may be explained by the shorter half-life of lumefantrine (3-6 days) compared to amodiaquine (9-18 days). The high reinfection rate suggests that there is a continued need to scale-up effective malaria prevention interventions.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014
    Magdalena Paczkowski
    Dyson Mwandama
    Daniel Marthey
    Madalitso Luka
    Georgina Makuta
    John Sande
    Doreen Ali
    Peter Troell
    Don P. Mathanga
    Julie Gutman
    [J]. Malaria Journal, 15
  • [2] EFFICACY OF ARTEMETHER-LUMEFANTRINE OR ARTESUNATE-AMODIAQUINE FOR UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA-MALAWI, 2014
    Paczkowski, Magdalena
    Mwandama, Dyson
    Marthey, Daniel
    Luka, Madalitso
    Makuta, Georgina
    Sande, John
    Ali, Doreen
    Troell, Peter
    Mathanga, Don
    Gutman, Julie
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2015, 93 (04): : 108 - 108
  • [3] EFFICACY OF ARTESUNATE-AMODIAQUINE AND ARTEMETHER-LUMEFANTRINE FOR UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA IN MADAGASCAR
    Rakotondrandriana, Antsa
    Rakotoarisoa, Arinomenjanahary
    Rakotomanga, Tovonahary Angelo
    Rason, Marie Ange
    Dentinger, Catherine M.
    Steinhardt, Laura Claire
    Souza, Samaly
    Lucchi, Naomi
    Udhayakumar, Venkatachalam
    Halsey, Eric
    Ratsimbasoa, Arsene
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 82 - 83
  • [4] Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018
    Dentinger, Catherine M.
    Rakotomanga, Tovonahary Angelo
    Rakotondrandriana, Antsa
    Rakotoarisoa, Arinomenjanahary
    Rason, Marie Ange
    Moriarty, Leah F.
    Steinhardt, Laura C.
    Kapesa, Laurent
    Razafindrakoto, Jocelyn
    Svigel, Samaly S.
    Lucchi, Naomi W.
    Udhayakumar, Venkatachalam
    Halsey, Eric S.
    Ratsimbasoa, C. Arsene
    [J]. MALARIA JOURNAL, 2021, 20 (01)
  • [5] Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018
    Catherine M. Dentinger
    Tovonahary Angelo Rakotomanga
    Antsa Rakotondrandriana
    Arinomenjanahary Rakotoarisoa
    Marie Ange Rason
    Leah F. Moriarty
    Laura C. Steinhardt
    Laurent Kapesa
    Jocelyn Razafindrakoto
    Samaly S. Svigel
    Naomi W. Lucchi
    Venkatachalam Udhayakumar
    Eric S. Halsey
    C. Arsène Ratsimbasoa
    [J]. Malaria Journal, 20
  • [6] Efficacy of artemether-lumefantrine and artesunate-amodiaquine for treating uncomplicated falciparum malaria in children
    Faranita, Tri
    Pasaribu, Ayodhia Pitaloka
    Ali, Muhammad
    Lubis, Munar
    Pasaribu, Syahril
    [J]. PAEDIATRICA INDONESIANA, 2012, 52 (05) : 260 - 266
  • [7] Efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in Tanzania
    Kabanywanyi, A. M.
    Ishengoma, D. S.
    Namamba, J.
    Ngasala, B.
    Njau, R.
    Kataraihya, J.
    Lemnge, M. M.
    Premji, Z.
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2011, 16 : 102 - 103
  • [8] Oral Artesunate-Amodiaquine and Artemether-Lumefantrine in the Treatment of Uncomplicated Hyperparasitaemic Plasmodium falciparum Malaria in Children
    Gbotosho, Grace O.
    Sowunmi, Akintunde
    Okuboyejo, Titilope M.
    Happi, Christian T.
    [J]. JOURNAL OF TROPICAL PEDIATRICS, 2012, 58 (02) : 151 - 153
  • [9] Efficacy and safety of artemether-lumefantrine and artesunate-amodiaquine in treating children with uncomplicated Plasmodium falciparum malaria in mainland Tanzania
    Syk, A.
    Mork, L. G.
    Mmbando, B.
    Mhamilawa, L. E.
    Ngasala, B.
    Martensson, A.
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2021, 26 : 97 - 97
  • [10] Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers
    Koko, Victor S.
    Warsame, Marian
    Vonhm, Benjamin
    Jeuronlon, Moses K.
    Menard, Didier
    Ma, Laurence
    Taweh, Fahn
    Tehmeh, Lekilay
    Nyansaiye, Paye
    Pratt, Oliver J.
    Parwon, Sei
    Kamara, Patrick
    Asinya, Magnus
    Kollie, Aaron
    Ringwald, Pascal
    [J]. MALARIA JOURNAL, 2022, 21 (01)